Are you Dr. Grossman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 39 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Summary
- Dr. Herbert Grossman, MD is a board certified urologist in Houston, Texas. He is currently licensed to practice medicine in Texas, Oklahoma, and Michigan. He is affiliated with University of Texas M.D. Anderson Cancer Center.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 1978 - 1980
- University of MichiganResidency, Urology, 1974 - 1977
- Trinity Health Ann Arbor HospitalResidency, Surgery, 1973 - 1974
- University of Michigan Health SystemInternship, Transitional Year, 1970 - 1971
- Lewis Katz School of Medicine at Temple UniversityClass of 1970
Certifications & Licensure
- OK State Medical License 2020 - 2021
- TX State Medical License 1995 - 2021
- CA State Medical License 1971 - 2019
- MI State Medical License 1973 - 2011
- American Board of Urology Urology
Clinical Trials
- Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB Start of enrollment: 2010 Jun 01
Publications & Presentations
PubMed
- 31 citationsWhole-Organ Genomic Characterization of Mucosal Field Effects Initiating Bladder Carcinogenesis.Tadeusz Majewski, Hui Yao, Jolanta Bondaruk, Woonbok Chung, Sangkyou Lee
Cell Reports. 2019-02-19 - 14 citationsIs folic acid safe for non–muscle-invasive bladder cancer patients? An evidence-based cohort studyHuakang Tu, Colin P.N. Dinney, Yuanqing Ye, H. Barton Grossman, Seth P. Lerner
The American Journal of Clinical Nutrition. 2018-02-01 - 24 citationsPhase 1b Trial to Evaluate Tissue Response to a Second Dose of Intravesical Recombinant Adenoviral Interferon α2b Formulated in Syn3 for Failures of Bacillus Calmette-...Neema Navai, William F. Benedict, Guangcheng Zhang, Alice Abraham, Nancy Ainslie
Annals of Surgical Oncology. 2016-07-07